| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |